×
Back to Agenda
Session 2: Clinical Trials – From Directive to Regulation
Session Chair(s)
Nick Sykes, MS
Policy Advisor, Regulatory Strategy, EFPIA, Belgium
This session will review issues related to clinical research, for Day 1 and looking forward. This will summarise what we know, what we still don’t know and what we have to do to be prepared. UK issues vs. EU 27: IMP supply and the complex transition via Brexit and then into the new system.
Speaker(s)
Niall Dickson
Chief Executive, NHS Confederation, United Kingdom
Emma Du Four, MBA
Independent Regulatory and R&D Policy Professional, Independent, United Kingdom
Emlyn Samuel
Senior Policy Manager, Cancer Research UK, United Kingdom
Have an account?